China Dasheng Biotechnology Co. (OTC PINK:CDBT) is set to rebrand as Cycclone Magnetic Engine Developments, Inc., under the leadership of newly appointed CEO Micheal Nugent. Nugent emphasized the challenges faced in developing unproven technologies, specifically focusing on permanent magnet engines. Despite past legal hurdles, the company is committed to advancing its projects, including low carbon emission engines and clean technology solutions. CDBT aims to consolidate assets in green energy sectors while protecting shareholder rights. The firm has entered an operating agreement to control its subsidiaries.
China Dasheng Biotechnology Co. (OTC:CDBT) announced the acceptance of effective control of Cycclone Magnetic Engine Developments Limited as of October 1, 2022. This follows a series of strategic transactions beginning July 2022, when a majority of voting rights were sold to Micheal Nugent. The company is focused on integrating green energy solutions and plans to consolidate assets for profitability. Cycclone aims to develop low carbon emission engines, enhancing energy efficiency and reducing greenhouse emissions from its base in Australia.